RRBP1

Ribosome-binding protein 1 · Q9P2E9 · RRBP1 on Sugi Atlas →

0 patent compounds predicted against RRBP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RRBP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer PHASE2COMPLETED
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) PHASE1UNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Gait in Rare Diseases nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Gene Expression in Patients With Epiretinal Membranes nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RRBP1 binder may also engage these)

ProteinNameSimilarity
Q28298 0.993 Q28298 →
Q99PL5 0.990 Q99PL5 →
P16884 0.976 P16884 →
O94913 0.973 O94913 →
P12036 0.973 P12036 →
Q9JJ11 0.972 Q9JJ11 →
P19246 0.972 P19246 →
Q61595 0.971 Q61595 →
Q90631 0.970 Q90631 →
B9EKI3 0.970 B9EKI3 →
TGOLN2 Trans-Golgi network integral membrane protein 2 0.970 landscape →
O42184 0.969 O42184 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.969 landscape →
Q0V9A3 0.969 Q0V9A3 →
P12957 0.968 P12957 →
Q0WVL7 0.968 Q0WVL7 →
Q9I969 0.968 Q9I969 →
Q8BMP6 0.968 Q8BMP6 →
A2ZLC1 0.968 A2ZLC1 →
Q7YS99 0.968 Q7YS99 →
Q28824 0.968 Q28824 →
Q8CGF7 0.968 Q8CGF7 →
A0JP43 0.967 A0JP43 →
P16053 0.967 P16053 →
Q5XGC9 0.967 Q5XGC9 →
Q870Q1 0.967 Q870Q1 →
O77788 0.967 O77788 →
Q6PH11 0.967 Q6PH11 →
G3X9Z4 0.967 G3X9Z4 →
P02894 0.967 P02894 →